Prof. Said Dermime is a distinguished scientist specializing in cancer immunology and immunotherapy, with over 30 years of experience in academia and research. He currently serves as the Senior Scientist and Director of the Translational Cancer Research Facility at the National Center for Cancer Care and Research (NCCCR) in Doha, Qatar. Additionally, he holds academic positions as an Adjunct Associate Professor at the College of Health and Life Sciences, Hamad Bin Khalifa University, and as a Clinical Professor of Biomedical Sciences at the College of Health Sciences, Qatar University. Dr. Dermime earned his PhD in Immunology from Salford University, Manchester, UK, in 1992. His professional journey includes significant roles such as leading the Lymphoma-Cancer Vaccine Team at the Paterson Institute for Cancer Research, Christie Hospital, Manchester, UK; serving as a Senior Scientist at King Faisal Specialist Hospital & Research Centre in Riyadh, Saudi Arabia; chairing the Department of Biomedical Research at Dasman Diabetes Institute; and leading the Department of Biomedical Research at King Fahad Specialist Hospital in Dammam, Saudi Arabia. Throughout his career, Dr. Dermime has contributed extensively to the field of cancer immunotherapy, focusing on designing and evaluating therapeutic and prophylactic strategies in both preclinical and clinical studies. His research has led to several notable discoveries, including identifying causes of resistance to retinoic acid